• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

A Bayer partner slims down, trimming R&D and enacting layoffs, to better focus on the...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Mar 24, 2022 at 11:12: AM
via A Bayer partner that co-developed an FDA-approved prostate cancer drug is joining some of its biotech compatriots and taking out its restructuring kit, announcing a swath of R&D changes and warning of potential layoffs Thursday morning.

article source
 

<



Similar threads

cafead
Bayer, Google partner on AI for time-pressed radiologists
Replies
0
Views
72
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Thermo Fisher, Bayer partner to develop companion diagnostics
Replies
0
Views
109
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Bayer, AI-Focused Aignostics Partner to Find New Oncology Targets
Replies
0
Views
88
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
JPM: CureVac&#039;s new pharma partner Bayer says its COVID-19 vaccine not just an also-ran
Replies
0
Views
187
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
That $335M JV Bayer set up on CRISPR/Cas9? They’re letting the biotech partner carry on
Replies
0
Views
134
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote